Gelesis Holdings, Inc.
GLSNYSEHealthcare
$0.16
+$0.00(+0.00%)
Market Cap$11630550
P/E Ratio—
52W High$5.67
52W Low$0.012
Gelesis Holdings, Inc. (GLS) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GLS · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2022-12 | 2021-12 |
|---|---|---|
| Operating Activities | ||
| Net Income | ($55.78M) | ($93.35M) |
| Depreciation & Amort. | $5.49M | $3.79M |
| Stock-Based Comp. | $29.78M | $5.53M |
| Change in Working Capital | ($7.26M) | $19.35M |
| Net Cash from Operations | ($77.73M) | ($55.29M) |
| Investing Activities | ||
| Capital Expenditure | ($9.12M) | ($19.92M) |
| Purchases of Investments | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $24.00M |
| Net Cash from Investing | ($9.12M) | $4.08M |
| Financing Activities | ||
| Common Stock Repurchased | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M |
| Net Cash from Financing | $66.33M | $32.53M |
| Free Cash Flow | ||
| Free Cash Flow | ($86.85M) | ($75.21M) |
| FCF Margin %(computed) | -337.05% | -672.40% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Gelesis Holdings, Inc. data
About Gelesis Holdings, Inc. (GLS) Cash Flow Statement
Gelesis Holdings, Inc. generated operating cash flow of ($0.08B) and free cash flow of ($0.09B) for 2022 — a FCF margin of -337.05%. Capital expenditure was ($0.01B).
Frequently asked questions
GLS · 4 questionsGelesis Holdings, Inc. generated free cash flow of ($0.09B) for 2022, down 15.5% year-over-year.
GLS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10